Jonathan H. Esensten

4.4k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Jonathan H. Esensten is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jonathan H. Esensten has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Jonathan H. Esensten's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Jonathan H. Esensten is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (7 papers). Jonathan H. Esensten collaborates with scholars based in United States, United Kingdom and Israel. Jonathan H. Esensten's co-authors include Jeffrey A. Bluestone, Ynes Helou, Gaurav Chopra, Arthur Weiss, Marc Martínez‐Llordella, Melanie Stumpf, Cristina Peñaranda, Michael R. F. Lee, Qizhi Tang and Amy Putnam and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jonathan H. Esensten

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD28 Costimulation: From Mechanism to Therapy

2016 623 citations Jonathan H. Esensten, Ynes Helou et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan H. Esensten United States	16	1.4k	678	437	326	181	21	2.3k
Jonathan S. Maltzman United States	25	1.8k 1.3×	789 1.2×	765 1.8×	156 0.5×	115 0.6×	60	3.0k
Hidefumi Hiramatsu Japan	19	917 0.6×	699 1.0×	834 1.9×	416 1.3×	92 0.5×	95	2.7k
Melissa E. Elder United States	19	1.3k 0.9×	321 0.5×	710 1.6×	606 1.9×	157 0.9×	48	2.4k
V. Koneti Rao United States	27	1.7k 1.2×	522 0.8×	709 1.6×	462 1.4×	166 0.9×	87	2.8k
Benjamin Joachim Schmiedel Germany	21	995 0.7×	488 0.7×	603 1.4×	184 0.6×	91 0.5×	44	1.7k
Huifang Lu United States	17	864 0.6×	418 0.6×	310 0.7×	122 0.4×	157 0.9×	58	2.0k
Hiroyuki Fujisaki Japan	24	1.3k 0.9×	1.0k 1.5×	725 1.7×	156 0.5×	232 1.3×	74	2.8k
Andrew G. Levine United States	7	1.4k 1.0×	421 0.6×	307 0.7×	152 0.5×	156 0.9×	9	2.0k
Michel Ticchioni France	30	1.3k 0.9×	343 0.5×	791 1.8×	205 0.6×	179 1.0×	72	2.7k
Fabian Flores‐Borja United Kingdom	19	2.2k 1.6×	416 0.6×	527 1.2×	204 0.6×	62 0.3×	34	3.0k

Countries citing papers authored by Jonathan H. Esensten

Since Specialization

Citations

This map shows the geographic impact of Jonathan H. Esensten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan H. Esensten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan H. Esensten more than expected).

Fields of papers citing papers by Jonathan H. Esensten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan H. Esensten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan H. Esensten. The network helps show where Jonathan H. Esensten may publish in the future.

Co-authorship network of co-authors of Jonathan H. Esensten

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan H. Esensten. A scholar is included among the top collaborators of Jonathan H. Esensten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan H. Esensten. Jonathan H. Esensten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Melocchi, Alice, Angela Lares, Marco Uboldi, et al.. (2025). Automated manufacturing of cell therapies. Journal of Controlled Release. 381. 113561–113561. 8 indexed citations

Esensten, Jonathan H., et al.. (2024). A roadmap for affordable genetic medicines. Nature. 634(8033). 307–314. 31 indexed citations

Dong, Shen, Kamir J. Hiam-Galvez, Cody T. Mowery, et al.. (2021). The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. JCI Insight. 6(18). 151 indexed citations

Balcerek, Joanna, Brian R. Shy, Amy Putnam, et al.. (2021). Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience. Frontiers in Immunology. 12. 744763–744763. 18 indexed citations

Bainbridge, Emma, Priscilla Y. Hsue, Jonathan H. Esensten, et al.. (2021). Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019. Open Forum Infectious Diseases. 8(8). ofab385–ofab385. 3 indexed citations

Lynch, Kara L., Jeffrey D. Whitman, Brian R. Shy, et al.. (2020). Magnitude and Kinetics of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity. Clinical Infectious Diseases. 72(2). 301–308. 126 indexed citations

Lindgren, Catherine, et al.. (2020). Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular Immunotherapy. Cytotherapy. 23(2). 157–164. 3 indexed citations

Okada, Kaori, Andrea Nguyen, Payal Watchmaker, et al.. (2019). Development of a large-scale H3.3K27M-specific TCR-transduced T cell manufacturing method for adoptive cell therapy in HLA-A2+ patients with diffuse midline glioma. Cytotherapy. 21(5). S36–S36. 1 indexed citations

Esensten, Jonathan H., Yannick D. Müller, Jeffrey A. Bluestone, & Qizhi Tang. (2018). Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier. Journal of Allergy and Clinical Immunology. 142(6). 1710–1718. 128 indexed citations

10.

Esensten, Jonathan H., Ynes Helou, Gaurav Chopra, Arthur Weiss, & Jeffrey A. Bluestone. (2016). CD28 Costimulation: From Mechanism to Therapy. Immunity. 44(5). 973–988. 623 indexed citations breakdown →

11.

Esensten, Jonathan H., Jeffrey A. Bluestone, & Wendell A. Lim. (2016). Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials. Annual Review of Pathology Mechanisms of Disease. 12(1). 305–330. 49 indexed citations

12.

McCleland, Mark L., Scot D. Liu, Jonathan H. Esensten, et al.. (2015). Cdk8 deletion in the Apc^Min murine tumour model represses EZH2 activity and accelerates tumourigenesis. The Journal of Pathology. 237(4). 508–519. 51 indexed citations

13.

Wiita, Arun P., Gerald W. Hsu, Chuanyi M. Lu, Jonathan H. Esensten, & James A. Wells. (2014). Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling. Proceedings of the National Academy of Sciences. 111(21). 7594–7599. 37 indexed citations

14.

Kouchkovsky, Dimitri de, Jonathan H. Esensten, Wendy Rosenthal, et al.. (2013). microRNA-17–92 Regulates IL-10 Production by Regulatory T Cells and Control of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 191(4). 1594–1605. 101 indexed citations

15.

Jeker, Lukas T., Dimitri de Kouchkovsky, Jonathan H. Esensten, & Jeffrey A. Bluestone. (2011). The miR-17-92 cluster is essential for regulatory T cell function in vivo (168.14). The Journal of Immunology. 186(1_Supplement). 168.14–168.14. 2 indexed citations

16.

Putnam, Amy, Michael R. F. Lee, Jonathan H. Esensten, et al.. (2011). Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes. The Journal of Immunology. 186(7). 3918–3926. 345 indexed citations

17.

Esensten, Jonathan H., et al.. (2011). Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunological Reviews. 241(1). 180–205. 302 indexed citations

18.

Esensten, Jonathan H., Michael R. F. Lee, Laurie H. Glimcher, & Jeffrey A. Bluestone. (2009). T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function. The Journal of Immunology. 183(1). 75–82. 58 indexed citations

19.

Esensten, Jonathan H., David Wofsy, & Jeffrey A. Bluestone. (2009). Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nature Reviews Rheumatology. 5(10). 560–565. 94 indexed citations

20.

Esensten, Jonathan H.. (2005). NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone. Nucleic Acids Research. 33(12). 3845–3854. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact